logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

New Drugs For Asthma Allergy And Copd Progress In Respiratory Research 1st Edition T T Hansel Editor

  • SKU: BELL-1670220
New Drugs For Asthma Allergy And Copd Progress In Respiratory Research 1st Edition T T Hansel Editor
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

New Drugs For Asthma Allergy And Copd Progress In Respiratory Research 1st Edition T T Hansel Editor instant download after payment.

Publisher: S Karger Pub
File Extension: PDF
File size: 7.2 MB
Pages: 400
Author: T. T. Hansel (Editor), Peter J. Barnes (Editor)
ISBN: 9780585441528, 9783805568623, 3805568622, 0585441529
Language: English
Year: 2001
Edition: 1

Product desciption

New Drugs For Asthma Allergy And Copd Progress In Respiratory Research 1st Edition T T Hansel Editor by T. T. Hansel (editor), Peter J. Barnes (editor) 9780585441528, 9783805568623, 3805568622, 0585441529 instant download after payment.

This book provides a state-of-the-art account by academic respiratory physicians and senior pharmaceutical industry personnel on the development of new drugs for asthma, allergy and COPD. It contains 80 chapters of highly condensed information, presented in an attractive, reader-friendly format with much use of tables, figures and diagrams. In addition to summarizing the diverse range of current approaches, this handbook also looks into the future, considering many topics that are promising, but have only emerged in the last few years. Developments within established drug categories such as beta-2-agonists, steroids and leukotriene antagonists are also reviewed. Never before has a single book brought together so many pharmaceutical drug developers sharing their experience on such a wide range of respiratory topics!

Related Products